EPISODE · Mar 5, 2026 · 36 MIN
Claas Kirchhelle and Lloyd Czaplewski on AMR governance and financing
from The Lancet Microbe in conversation with · host The Lancet Group
Elena Dalla Vecchia talks with Claas Kirchhelle and Lloyd Czaplewski about the current antimicrobial resistance (AMR) governance (with a historical perspective on how it came to be), the 2015 WHO Global Action Plan (GAP) on AMR and the draft for the 2026 updated GAP, the role of social sciences in addressing AMR, the financing mechanisms in antibiotic research and development (including push and pull incentives with public and philantropic funding), and perspectives on the future of the fight against AMR. Click here to read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00243-5/fulltext https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00216-2/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Embed this episode
What this episode covers
Elena Dalla Vecchia talks with Claas Kirchhelle and Lloyd Czaplewski about the current antimicrobial resistance (AMR) governance (with a historical perspective on how it came to be), the 2015 WHO Global Action Plan (GAP) on AMR and the draft for the 2026 updated GAP, the role of social sciences in addressing AMR, the financing mechanisms in antibiotic research and development (including push and pull incentives with public and philantropic funding), and perspectives on the future of the fight...
NOW PLAYING
Claas Kirchhelle and Lloyd Czaplewski on AMR governance and financing
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.